Cargando…
Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins
The mechanism by which the drug rapamycin inhibits the mechanistic target of rapamycin (mTOR) is of intense interest because of its likely relevance in cancer biology, aging, and other age-related diseases. While rapamycin acutely and directly inhibits mTORC1, only chronic administration of rapamyci...
Autores principales: | Schreiber, Katherine H, Ortiz, Denise, Academia, Emmeline C, Anies, Arieanna C, Liao, Chen-Yu, Kennedy, Brian K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364838/ https://www.ncbi.nlm.nih.gov/pubmed/25652038 http://dx.doi.org/10.1111/acel.12313 |
Ejemplares similares
-
Interactions of FK506 and Rapamycin With FK506 Binding Protein 12 in Opportunistic Human Fungal Pathogens
por: Vellanki, Sandeep, et al.
Publicado: (2020) -
The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin
Publicado: (1992) -
A novel rapamycin analog is highly selective for mTORC1 in vivo
por: Schreiber, Katherine H., et al.
Publicado: (2019) -
Tomato FK506 Binding Protein 12KD (FKBP12) Mediates the Interaction between Rapamycin and Target of Rapamycin (TOR)
por: Xiong, Fangjie, et al.
Publicado: (2016) -
Natural product ligands of FKBP12: Immunosuppressive antifungal agents FK506, rapamycin, and beyond
por: Rivera, Angela, et al.
Publicado: (2023)